Form D · Pharmaceuticals
ADVAC Therapeutics Inc
Columus, OH · CIK 0002115406
Offering snapshot reported Mar 10, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 6, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 10, 2026 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-576078
Source: Form D, filed Mar 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Walter Gossett | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2281 Kenny Road Suite 410
Columus, OH, 43210
Phone: 9082853087
Columus, OH, 43210
Phone: 9082853087